Avista Healthcare Partners has completed its acquisition of PK Benelux, a major player in the Netherlands’ vitamins, minerals, and supplements market. The transaction strengthens Avista’s position in the consumer health sector. And it marks the firm’s seventh platform investment in this category, extending its strategy of partnering with founder-led businesses across North America and Western Europe.
PK Benelux, founded in 1985 and headquartered in Uden, is recognized as the leading supplier of vitamins, minerals, and supplements in the Netherlands. Its flagship brand, Lucovitaal, has been the fastest-growing brand in the country for five consecutive years. The business remains operated by its second-generation founders, Albert Peters and Angela Steenbergen-Peters, who have built a comprehensive portfolio spanning nearly every major VMS category.
The company markets vitamins, minerals, supplements, and broader health products primarily through Dutch pharmacies and drugstores. And it also develops white-label and private-label medical devices that are sold in more than 30 countries.
Avista’s approach to scaling founder-driven companies played a central role in forming the partnership with PK Benelux. The transaction is further supported by Avista’s established network of experienced executives and represents the private equity firm’s third collaboration with Yvan Vindevogel and the Damier Group.
Founded in 2005, Avista Healthcare Partners has invested more than $10 billion across 51 healthcare businesses globally. The New York–based firm focuses on product and technology companies with strong management, stable cash flow, and growth opportunities across six healthcare sub-sectors benefiting from favorable market conditions. Its team of Strategic Executives provides additional operational insight aimed at long-term value creation.
